ArticleNature medicine2024
Antisense oligonucleotide therapy in an individual with KIF1A-associated neurological disorder.
Alban Ziegler et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
33 papers cite it
this papertrialcites it